Electromed (ELMD) director reports 3,000-share restricted stock grant and 15,000 shares owned

Rhea-AI Filing Summary

Electromed, Inc. reported that one of its directors acquired 3,000 shares of common stock as a restricted stock award on December 1, 2025 at a stated price of $0 per share. After this award, the director beneficially owns 15,000 shares of Electromed common stock in direct ownership form. The restricted stock is scheduled to vest on June 1, 2026, unless vesting is accelerated or the award is terminated under its terms, meaning the director must remain eligible through that date to receive the shares without restrictions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Galatowitsch Joseph L.

(Last) (First) (Middle)

500 SIXTH AVENUE NW

(Street)

NEW PRAGUE MN 56071

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Electromed, Inc. [ ELMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/01/2025		A		3,000(1)	A	$0	15,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.

	/s/ Joshua L. Colburn, Attorney-in-fact	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Electromed (ELMD) disclose in this Form 4?

Electromed disclosed that a director received a grant of 3,000 shares of restricted common stock on December 1, 2025 at a stated price of $0 per share.

How many Electromed (ELMD) shares does the reporting person own after this transaction?

Following the reported restricted stock award, the reporting person beneficially owns 15,000 shares of Electromed common stock in direct ownership.

What is the vesting schedule of the 3,000 restricted Electromed (ELMD) shares?

The 3,000 restricted shares are scheduled to vest on June 1, 2026, unless vesting is earlier accelerated or the award is terminated pursuant to its terms.

What is the role of the reporting person at Electromed (ELMD)?

The reporting person is a director of Electromed, Inc., as indicated in the relationship section of the disclosure.

Does this Electromed (ELMD) Form 4 report any derivative securities?

The filing format includes a table for derivative securities, but the provided content does not list any derivative transactions or holdings.

Who signed the Electromed (ELMD) Form 4 and on what date?

The Form 4 was signed by Joshua L. Colburn as attorney-in-fact on December 3, 2025.